Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trial

This hypothesis-generating win ratio analysis, integrating death, thrombotic events, and major bleeds with and without quality of life, did not find an advantage of anticoagulation with edoxaban over no anticoagulation in patients with DDAF. The most common events were death and major bleeding.

Authors

Institutions

Publication Details

Journal
European Heart Journal - Quality of Care and Clinical Outcomes
Published
2025-08-14
DOI
https://doi.org/10.1093/ehjqcco/qcaf087
Citations
3
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
4.16

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trial

Éloi Marijon, Wolfgang Dichtl, Tobias Toennis, Andrzej Lubiński et al.
3 citations
European Heart Journal - Quality of Care and Clinical Outcomes
Atrial Fibrillation Management and Outcomes
4.16
article

Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trial

Éloi Marijon, Wolfgang Dichtl, Tobias Toennis, Andrzej Lubiński, Emanuele Bertaglia, Gheorghe‐Andrei Dan, Carina Blomström‐Lundqvist, Lieven Nils Kennes, Hans‐Christoph Diener, Andreas Goette, Εmmanuel Simantirakis, Nuno Cabanelas, Vasil Velchev, Axel Brandes, Kim Rajappan, Ulrich Schotten, Paulus Kirchhof, Nina Becher, Lluı́s Mont, Antonia Zapf, Susanne Sehner, Melanie Calvert, Gregory Chlouverakis, Andrea Sarkozy, Dan Wichterle, Joris R. de Groot, Vincent Beuger, Ursula Rohrer, Alexander Fierenz, Béla Merkely, Panos Vardas, Gregory Y. H. Lip, A. John Camm, Gina Köllner
article en
3 citations

Abstract

This hypothesis-generating win ratio analysis, integrating death, thrombotic events, and major bleeds with and without quality of life, did not find an advantage of anticoagulation with edoxaban over no anticoagulation in patients with DDAF. The most common events were death and major bleeding.

European Heart Journal - Quality of Care and Clinical OutcomesVol. 11(8)
Semmelweis University (HU), Uppsala University (SE), University of Padua (IT), University of Crete (GR), Innsbruck Medical University (AT), University of Liverpool (GB), Universität Hamburg (DE), Carol Davila University of Medicine and Pharmacy (RO), St George's, University of London (GB), University of Southern Denmark (DK), City, University of London (GB), Medical University of Graz (AT), Paderborn University (DE), Örebro University (SE), John Radcliffe Hospital (GB), Medical University of Sofia (BG), Academia Oamenilor de Știință din România (RO), Maastricht University (NL), Institut für Medizinische Informatik, Biometrie und Epidemiologie (DE), Liverpool Heart and Chest Hospital (GB), Biomedical Research Foundation of the Academy of Athens (GR), Hospital Prof. Dr. Fernando Fonseca (PT), Hôpital Européen Georges-Pompidou (FR), University Medical Center Hamburg-Eppendorf (DE), Atrial Fibrillation NETwork (DE), Centro de Investigación Biomédica en Red (ES), Hospital Clínic de Barcelona (ES), Universitair Ziekenhuis Brussel (BE), German Centre for Cardiovascular Research (DE), Institute of Clinical and Experimental Medicine (CZ), Brüderkrankenhaus St. Josef Paderborn (DE), St. Vincenz-Krankenhaus Limburg (DE), Hospital South West Jutland (DK), University Hospital of Heraklion (GR), European Hospital (IT), University of Applied Sciences Stralsund (DE), Amsterdam University Medical Centers (NL), Centro de Investigación Biomédica en Red de Cáncer (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), NIHR Birmingham Biomedical Research Centre (GB), University of Duisburg-Essen (DE), Gdańsk Medical University (PL), University of Birmingham (GB), Aalborg University (DK), Otto-von-Guericke-Universität Magdeburg (DE)
Deutsches Zentrum für Herz-Kreislaufforschung, Kompetenznetz Vorhofflimmern, British Heart Foundation, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Frauen, Daiichi Sankyo Europe
Openalex Percentile: Top 5%
Atrial Fibrillation Management and Outcomes
4.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.